JOSHUA OGLEHART: Open Payments
NPI 1811338999 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,554 in 108 payments from 15 companies in 2025. Trend: 2023 $1,309 · 2024 $3,524 · 2025 $2,554
Food & beverage: $2,453Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $484 |
| Neurocrine BioSciences, Inc. | 15 | $434 |
| ABBVIE INC. | 21 | $412 |
| Otsuka America Pharmaceutical, Inc. | 19 | $347 |
| Janssen Pharmaceuticals, Inc | 14 | $261 |
| Luye Pharma (USA) Ltd. | 9 | $200 |
| Indivior Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| Alkermes, Inc. | 2 | $43 |
Products named: INGREZZA, VRAYLAR, AUSTEDO XR, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, ABILIFY ASIMTUFII, ABILIFY MAINTENA, SUBLOCADE.
Industry payments across OH — which companies pay providers there.
